Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification
A Long-term Evaluation of Single-piece Hydrophobic Acrylic Intraocular Lens Implantation on the Development of Posterior Capsule Opacification
1 other identifier
observational
390
1 country
1
Brief Summary
Although contemporary cataract surgery has made tremendous strides in technological advancement, posterior capsular opacification (PCO) is still the most frequent long-term complication leading to decreased visual functions and thereby dissatisfying results. A great deal of effort has been made to develop new ways to prevent the formation of PCO. A key factor, widely discussed in literature, is the material and design of the intraocular lense (IOL) edge that can lead to PCO prevention. It is still not clear whether the sharp-edged IOL produces less PCO because of its optic geometry alone or whether the biomaterial contributes to the inhibition of PCO. With the clinical introduction of the single-piece acrylic hydrophobic IOLs with some optic and haptic design differences compared with three-piece acrylic hydrophobic IOLs, it has become possible to determine the influence of IOL material and design on PCO prevention. It is well established that the development of PCO is a dynamic process and that a longer follow-up time is correlated with a higher degree of PCO. So far, there have been prospective clinical studies on the clinical results of single and three-piece acrylic hydrophobic foldable IOLs. However, the question as to as to whether the PCO further increases or becomes stable or regresses on a long-term basis has not yet been answered. Since there is paucity of available literature that prospectively evaluates the development of PCO with the implantation of the single-piece SN60AT hydrophobic acrylic IOL on a long-term basis, the investigators decided to observe the degree of development of PCO at 5 years after cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 25, 2013
CompletedFirst Posted
Study publicly available on registry
March 28, 2013
CompletedMarch 28, 2013
March 1, 2013
6.3 years
March 25, 2013
March 27, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Posterior Capsule Opacification
Evaluation of PCO (EPCO) scores in the area of the intraocular lens (IOL) optic and in the central 3mm zone at 5 years after surgery
5 years followup
Secondary Outcomes (1)
EPCO Score and EPCO area with total on and part on anterior capsulorhexis cover over optic
5 years postoperatively
Other Outcomes (1)
Change in PCO at different followup intervals
upto 5 years postoperatively
Study Arms (1)
Patients undergoing phacoemulsification
Patients undergoing phacoemulsification for age-related cataract with implantation of a single-piece Acrysof IOL (SN60AT)
Interventions
Phacoemulsification with implantation of single piece Acrysof IOL
Eligibility Criteria
Patients undergoing phacoemulsification for age-related uncomplicated phacoemulsification
You may qualify if:
- patients with uncomplicated age-related cataract who were otherwise healthy
You may not qualify if:
- a history of diabetes mellitus (DM),
- patients with glaucoma,
- high myopia (axial length \> 27.0 mm),
- pseudoexfoliation,
- traumatic cataract,
- subluxated cataract,
- previous ocular surgeries, and
- allergy to dilating drops.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Iladevi Cataract & IOL Research Centre
Ahmedabad, Gujarat, 380052, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abhay R Vasavada, MS, FRCS
Iladevi Cataract & IOL Research Centre
- PRINCIPAL INVESTIGATOR
Abhay R Vasavada, MS,FRCS
Iladevi Cataract & IOL Research Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Iladevi Cataract and IOL Research Center
Study Record Dates
First Submitted
March 25, 2013
First Posted
March 28, 2013
Study Start
June 1, 2005
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
March 28, 2013
Record last verified: 2013-03